33
Active Trials
16
Phase 1
13
Phase 2
7
Phase 3
4
Therapeutic Areas
Portfolio Concentration: 91% of active trials in Oncology
Oncology
30 active / 31 total
Solid Tumor (Advanced)
12 active
12 total since 2015
Colorectal Cancer
3 active
3 total since 2015
NSCLC
3 active
1 Ph3
3 total since 2015
Sarcoma
3 active
1 Ph3
3 total since 2015
Ovarian Cancer
2 active
1 Ph3
2 total since 2015
Prostate Cancer
2 active
2 total since 2015
SCLC
1 active
1 Ph3
2 total since 2015
MDS
1 active
1 total since 2015
Endometrial Cancer
1 active
1 total since 2015
Head and Neck Cancer
1 active
1 total since 2015
Lung Cancer (General)
1 active
1 Ph3
1 total since 2015
Immunology
5 active / 6 total
CNS
2 active / 2 total
Cardiovascular
1 active / 1 total
Click an indication to see competitive landscape (all sponsors in that indication).
Data: ClinicalTrials.gov (2015+)